Wird geladen...
HER2/neu Immunostaining in Invasive Breast Cancer: Analysis of False Positive Factors
OBJECTIVES: HER2/neu gene amplification by Fluorescent in situ hybridization and protein expression by immunohistochemistry have been used for prognosis and guidance for the treatment of invasive ductal carcinoma of the breast with Trastuzumab. False positive results are a significant problem where...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
OMJ
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3191663/ https://ncbi.nlm.nih.gov/pubmed/22043354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2010.78 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|